Nanox Issues Going Concern Warning as Shares Plunge Nearly 50%

25 June, 2026

The medical imaging company withdrew its 2026 revenue guidance, abandoned its annual target and warned of substantial doubt about its ability to continue as a going concern

Shares of Nano-X Imaging plunged nearly 50% in Nasdaq trading on Thursday, leaving the company with a market capitalization of approximately $50 million. The sharp decline followed the release of the company’s first-quarter 2026 financial results and earnings call, during which management delivered a series of negative updates, including the withdrawal of its full-year revenue guidance and a going concern warning tied to the need for additional financing.

Nanox, which is developing the Nanox.ARC digital X-ray imaging system based on a proprietary X-ray source technology, aims to transform the medical imaging market with lower-cost, cloud-connected imaging systems integrated with artificial intelligence. In addition to its imaging platform, the company operates businesses in teleradiology, AI software and healthcare IT. After securing regulatory approvals and beginning its initial commercial rollout, the company is now focused on expanding customer deployments and converting pilot programs and distribution agreements into recurring revenue.

According to management, however, the transition from early commercialization to meaningful revenue generation is taking longer than expected. As a result, the company withdrew its 2026 revenue guidance. Earlier this year, Nanox had projected approximately $35 million in revenue for 2026, but it now says that target is no longer achievable.

“We no longer expect to achieve the revenue target previously announced for 2026,” CEO Erez Meltzer said during the earnings call. He added that, “we do not currently intend to provide annual revenue guidance going forward.”

According to the company, the timeline between signing commercial agreements, deploying systems, activating customer sites and recognizing revenue has proven longer than expected due to factors including site readiness, infrastructure completion, customer implementation schedules, activation timing and regulatory requirements.

The more significant concern emerged in the financial section of the report. Nanox disclosed that “These factors raise substantial doubt as to the company’s ability to continue as a going concern.” At the same time, management said it is actively seeking additional funding through private equity and the capital markets, warning that any equity financing could dilute existing shareholders. The company also stated that if it fails to secure additional funding, it may be forced to delay, reduce or eliminate parts of its product development and commercialization efforts.

The balance sheet illustrates why investors reacted so strongly. At the end of the first quarter, Nanox held $44.2 million in cash, cash equivalents and deposits, down from $60 million at the end of 2025. The company also disclosed that, on a preliminary unaudited basis, its cash and cash equivalents, net of short-term bank loans, had fallen to approximately $27 million by the date of the earnings release. During the quarter, Nanox generated negative operating cash flow of $14 million.

Operationally, the company reported first-quarter revenue of $4.3 million, up from $2.8 million a year earlier, primarily driven by growth in its teleradiology and Health IT businesses. Net loss for the quarter totaled $14.3 million, compared with $13.2 million in the same period last year.

During the earnings call, management emphasized that commercial deployment activity is improving and highlighted newly signed distribution agreements that could eventually result in hundreds of system sales over the coming years. However, when analysts asked about second-quarter performance and the expected pace of growth, the company declined to provide numerical guidance. Meltzer said only that “Q2 will be better than Q1,” while suggesting that a more meaningful acceleration is expected in the third and fourth quarters, following the onboarding and training of distribution partners. Those assurances failed to ease investor concerns, sending the stock to one of its steepest single-day declines since the company went public.

Share via Whatsapp

Posted in: News

Posted in tags: Going Concerns , nanox

Other articles you might like

"This May Be the Fastest ASIC Development Cycle Ever Achieved"

Hailo Lays Off Half Its Workforce as It Seeks a Buyer or Investor

Shifters Raises $10.2 Million: “The Robot Should Enter Before the Soldier”